Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 3/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.35 |
| ▸ | HTR6 | P50406 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | GBA1 | P04062 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7639864 | 0.81 | HTR2A (0.35) | SIGMAR1HTR6HTR2ATSHR | |
| SCHEMBL5702757 | 0.81 | SIGMAR1 (0.36) | SIGMAR1HTR6HTR2ATSHR | |
| SCHEMBL9779213 | 0.81 | SIGMAR1 (0.36) | SIGMAR1HTR6HTR2ATSHR | |
| SCHEMBL6055183 | 0.79 | SIGMAR1 (0.37) | SIGMAR1HTR6HTR2ALMNAKDM4E | |
| SCHEMBL27484012 | 0.78 | HTR6 (0.33) | SIGMAR1HTR6HTR2A | |
| SCHEMBL30084537 | 0.78 | SIGMAR1 (0.38) | SIGMAR1HTR6HTR2ALMNAKDM4E | |
| SCHEMBL27515506 | 0.78 | HTR2A (0.37) | SIGMAR1HTR6HTR2ALMNAKDM4E | |
| SCHEMBL27261195 | 0.77 | HTR2A (0.35) | SIGMAR1HTR6HTR2A | |
| SCHEMBL29288263 | 0.75 | HTR6 (0.32) | SIGMAR1HTR6HTR2A | |
| Hydrochloric Acid SCHEMBL30216611 | 0.75 | HTR2A (0.36) | SIGMAR1HTR6HTR2ALMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090247551-A1 | SUBSTITUTED ENAMINOCARBONYL COMPOUNDS | BAYER CROPSCIENCE AG (DE) | 2009-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090247551-A1 | SUBSTITUTED ENAMINOCARBONYL COMPOUNDS | DDT, NPEPPS, L3MBTL4 | EPHX1 1284/4885SIGMAR1 4045/4885HTR6 4619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.